During Equine Herpesvirus Myeloencephalopathy (EHM) incidents, the state animal health officials’ (SAHO) goal is to prevent the spread of the disease agent, specifically Equine Herpesvirus-1. Science-based disease control protocols, adapted to the specific incident, control disease spread while ensuring compliance and minimizing the impact on equine movement.
There is no single protocol that can be applied to all EHM incidents as there are multiple factors that must be considered when determining the optimal disease containment response. This guidance document provides SAHOs with science- and field experience-based control guidance to be considered during an EHM incident. This guidance document is an evolving document.
Related Resources
Position on the Use of Medroxyprogesterone Acetate in Competition Horses
Medroxyprogesterone acetate (MPA) is a synthetic progestin hormone administered to mares off-label…
Breeding Terminology
In providing written reports to interested parties, the AAEP encourages all equine…
Position on the Use of Horses in Urban Environments
The AAEP supports the use of horses and other equids in urban…